Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing
What this study shows
Explains why mTORC1 stays switched on in senescent cells. In human fibroblasts rendered senescent three different ways, mTORC1 is constitutively active and no longer responds to serum or amino acid withdrawal. The defect is upstream, not in mTORC1 itself: it is driven in part by depolarisation of the senescent plasma membrane, which leads to primary cilia defects and a failure to shut off growth-factor signalling, while increased autophagy and high intracellular amino acid levels may act to support the nutrient arm. Correcting these inputs restored sensitivity of the pathway and killed the cells, which frames persistent mTORC1 signalling as a survival dependency of senescent cells rather than a by-product of senescence.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Human fibroblasts made senescent by stress, replicative exhaustion or oncogene activation) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Human fibroblasts made senescent by stress, replicative exhaustion or oncogene activation |
| Journal | The Journal of cell biology |
| Year | 2017 |
| Peer reviewed | Yes |
| Record last updated | 2026-09-23 |
| Source | DOI 10.1083/jcb.201610113 · PMID 28566325 |